{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1047.447","meta":{"versionId":"9","lastUpdated":"2016-12-23T01:00:03.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Oncology Nursing Society Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2016-12-23"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.447","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1047.447"}],"version":"20161223","name":"Trastuzumab","title":"Trastuzumab","status":"active","experimental":false,"date":"2016-12-23T01:00:03-05:00","publisher":"Oncology Nursing Society Steward","description":"ONS measure set","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The intent is to capture the drug Trastuzumab as ordered),(Data Element Scope: This data element is intended to capture the population of breast cancer survivors within the first year post treatment who did receive Trastuzumab.  Using the Quality Data Model, this data element would map to the Medication category.),(Inclusion Criteria: Trastuzumab injectable medication is included),(Exclusion Criteria: Excluded are codes that do not meet inclusion criteria)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1162762","display":"trastuzumab Injectable Product"},{"code":"377216","display":"trastuzumab Injectable Solution"},{"code":"540885","display":"trastuzumab Injectable Solution [Herceptin]"},{"code":"806572","display":"trastuzumab 22 MG/ML"},{"code":"806573","display":"trastuzumab 22 MG/ML Injectable Solution"},{"code":"806574","display":"trastuzumab 22 MG/ML [Herceptin]"},{"code":"806575","display":"trastuzumab 22 MG/ML Injectable Solution [Herceptin]"}]}]},"expansion":{"identifier":"urn:uuid:a6615916-b749-4ece-8833-ad485dd11849","timestamp":"2023-12-10T20:55:01-05:00","total":5,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1162762","display":"trastuzumab Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"377216","display":"trastuzumab Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"540885","display":"trastuzumab Injectable Solution [Herceptin]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"806572","display":"trastuzumab 22 MG/ML"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"806573","display":"trastuzumab 22 MG/ML Injectable Solution"}]}}